EUVIMEDEUVIMED entdecken
Crossref

Plasmin-PAI-1 Imbalance Contributes to Hyperglycemia-Induced Vascular Calcification

Yosuke Kanno, Moeko Okuno, Osamu Matsuo, Kei-Ichi Ozaki

Journal of Vascular Research · 14.03.2026 · 63 (4) · 244-254

DOI: 10.1159/000551570 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Vascular Research, online erschienen am 14.03.2026. Verfasst von Yosuke Kanno und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pathology, Faculty of Pharmaceutical Science, Doshisha Women's College of Liberal Arts, Kyoto, Japan, ykanno@dwc.doshisha.ac.…. Hauptthemen laut MEDLINE: Fibrinolysin, Plasminogen Activator Inhibitor 1, Hyperglycemia, Vascular Calcification. Die Arbeit nennt 63 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Vascular calcification (VC) is a frequent complication in diabetes and is linked to an increased risk of thrombotic cardiovascular events. Diabetes is characterized by impaired fibrinolysis, and accumulating evidence implicates fibrin deposition in VC progression. However, how fibrinolytic dysregulation contributes to VC remains unclear.

Methods

We examined the role of fibrinolytic factors in VC using an established in vitro model. Vascular smooth muscle cells were cultured under high glucose conditions to evaluate glucose-induced VC and plasminogen activator inhibitor-1 (PAI-1) expression. In addition, exogenous plasmin stimulation was performed to assess its effects on VC progression and anti-calcific signaling.

Results

High glucose enhanced VC and markedly increased PAI-1 expression. Inhibition of PAI-1 signaling attenuated glucose-induced VC, indicating its involvement in VC development under hyperglycemia. Conversely, exogenous plasmin reduced VC under normoglycemic conditions. Short-term plasmin stimulation activated AMP-activated protein kinase (AMPK) and endothelial nitric oxide synthase (eNOS), both known inhibitors of VC.

Conclusion

These findings suggest that PAI-1 contributes to hyperglycemia-related VC, whereas plasmin exerts protective effects partly through AMPK-eNOS activation. Modulating plasmin activity or targeting PAI-1 may represent potential therapeutic approaches to prevent VC progression in diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibrinolysinPlasminogen Activator Inhibitor 1HyperglycemiaVascular CalcificationMuscle, Smooth, VascularMyocytes, Smooth MuscleGlucoseNitric Oxide Synthase Type IIIAMP-Activated Protein KinasesSignal TransductionHumansAnimalsCells, Cultured

Stichwörter der Autor:innen

AMPKHyperglycemiaPAI-1PlasminVascular calcification

Substanzen

FibrinolysinNitric Oxide Synthase Type IIIAMP-Activated Protein KinasesPlasminogen Activator Inhibitor 1GlucoseSERPINE1 protein, human

Autor:innen und Institutionen

  • Department of Molecular Pathology, Faculty of Pharmaceutical Science, Doshisha Women's College of Liberal Arts, Kyoto, Japan, ykanno@dwc.doshisha.ac.jp.
  • Department of Molecular Pathology, Faculty of Pharmaceutical Science, Doshisha Women's College of Liberal Arts, Kyoto, Japan.
  • Faculty of Medicine, Kindai University, Osaka, Japan.

Zitieren

APA

Kanno, Y., Okuno, M., Matsuo, O., & Ozaki, K. I. (2026). Plasmin-PAI-1 Imbalance Contributes to Hyperglycemia-Induced Vascular Calcification. Journal of Vascular Research, 63(4), 244-254. https://doi.org/10.1159/000551570

Vancouver

Kanno Y, Okuno M, Matsuo O, Ozaki KI. Plasmin-PAI-1 Imbalance Contributes to Hyperglycemia-Induced Vascular Calcification. Journal of Vascular Research. 2026;63(4):244-254. doi:10.1159/000551570

BibTeX
@article{Kanno2026,
  author = {Kanno, Yosuke and Okuno, Moeko and Matsuo, Osamu and Ozaki, Kei-Ichi},
  title = {Plasmin-PAI-1 Imbalance Contributes to Hyperglycemia-Induced Vascular Calcification},
  journal = {Journal of Vascular Research},
  year = {2026},
  volume = {63},
  number = {4},
  pages = {244--254},
  doi = {10.1159/000551570}
}
Kostenlos starten →